Research map: Multiplex microblot array as an integrated approach to ANA screening and antigen-specific profiling in systemic autoimmune rheumatic diseases

Back to the article

Papers in this map

  1. Current Concepts and Future Directions for the Assessment of Autoantibodies to Cellular Antigens Referred to as Anti-Nuclear Antibodies · Michael Mähler · 2014 · 203 citations · Cited by this paper
  2. Responsibility without a map: defining oversight of automated result release in the medical laboratory · 2026 · Related
  3. From ANA to ENA: How to proceed? · Jan G.M.C. Damoiseaux · 2005 · 120 citations · Cited by this paper
  4. Season of sampling and the interpretation of serum homocysteine results: a within-person analysis of 268,877 health-screening examinations · 2026 · Related
  5. Challenges in the Standardization of Autoantibody Testing: a Comprehensive Review · Renato Tozzoli · 2016 · 71 citations · Cited by this paper
  6. Delivering the EU Safe Hearts Plan: the essential role of laboratory medicine in cardiovascular health · 2026 · Related
  7. The association of solid-phase assays to immunofluorescence increases the diagnostic accuracy for ANA screening in patients with autoimmune rheumatic diseases · Nicola Bizzaro · 2018 · 68 citations · Cited by this paper
  8. Clinical utility of a dedicated vanishing twin analytical workflow in single-nucleotide variant-based non-invasive prenatal testing: a case report of resolving prolonged aneuploidy discordance · 2026 · Related
  9. The Past, Present, and Future in Antinuclear Antibodies (ANA) · Juan Irure‐Ventura · 2022 · 49 citations · Cited by this paper
  10. Frontmatter · 2025 · Related
  11. Comments on recent advances and recommendations for the assessment of autoantibodies to cellular antigens referred as antinuclear antibodies · Michael Mähler · 2014 · 43 citations · Cited by this paper
  12. Availability and characteristics of external quality assessment (EQA) schemes for measurement of hemolysis, icterus and lipemia (HIL) in routine coagulation testing, a collaborative study from the European Organisation for External Quality Assurance in Laboratory Medicine (EQALM) · 2026 · Related
  13. Autoantibodies testing in autoimmunity: Diagnostic, prognostic and classification value · Savino Sciascia · 2023 · 37 citations · Cited by this paper
  14. Refrigerated storage stability of 11 humoral parameters in two different venous blood collection tubes over a 7-day period · 2026 · Related
  15. Multiparametric autoantibody analysis: a new paradigm for the diagnosis of connective tissue diseases · Nicola Bizzaro · 2022 · 21 citations · Cited by this paper
  16. The correct use of the unit symbols U/L and IU/L · 2026 · Related
  17. Antinuclear Antibody Testing: Gold Standard Revisited · Marvin J. Fritzler · 2021 · 12 citations · Cited by this paper
  18. Thyroglobulin antibody in differentiated thyroid cancer: international laboratory practice survey and the case for a dual-threshold model · 2026 · Related
  19. Analytical aspects of the antinuclear antibody test by HEp-2 indirect immunofluorescence: EFLM report on an international survey · Martine J. Vercammen · 2023 · 7 citations · Cited by this paper
  20. Autoantibody status according to multiparametric assay accurately estimates connective tissue disease classification and identifies clinically relevant disease clusters · Giacomo Cafaro · 2023 · 7 citations · Cited by this paper
  21. Issues in autoantibody tests used in the classification criteria for autoimmune rheumatic diseases: the laboratory autoimmunologist's perspective · Nicola Bizzaro · 2024 · 5 citations · Cited by this paper
  22. Evaluation of a New Multiparametric Microdot Array-Based Immunoassay Panel for Systemic Autoimmune Disease Diagnosis · Maria Giaele Infantino · 2024 · 4 citations · Cited by this paper
  23. Harmonization of anti-nuclear antibody testing (ANA) by indirect immunofluorescence assay: Results from ten years of UK NEQAS external quality assessment · Maria Giaele Infantino · 2024 · 4 citations · Cited by this paper
  24. Diagnostic performance of particle-based multi-analyte technology compared to indirect immunofluorescence in screening for anti-nuclear antibodies in patients with autoimmune rheumatic diseases · Francesca Buzzulini · 2025 · 4 citations · Cited by this paper
  25. International expert consensus recommendations on standardised nomenclature of SSA/Ro (TROVE2/Ro60 and TRIM21/Ro52) autoantibodies in autoimmune diseases · Roko P.A. Nikolic · 2026 · 3 citations · Cited by this paper

Source: OpenAlex (CC0)